Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-10-22
1998-12-29
Huff, Sheela
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 530399, 530350, A61K 3800
Patent
active
058542205
ABSTRACT:
Disclosed is the characterization and purification of DNA encoding a numerous polypeptides useful for the stimulation of glial cell (particularly, Schwann cell) mitogenesis and treating glial cell tumors. Also disclosed are DNA sequences encoding novel polypeptides which may have use in stimulating glial cell mitogenesis and treating glial cell tumors. Methods for the synthesis, purification and testing of both known and novel polypeptides for their use as both therapeutic and diagnostic aids in the treatment of diseases involving glial cells are also provided. Methods are also provided for the use of these polypeptides for the preparation of antibody probes useful for both diagnostic and therapeutic use in diseases involving glial cells.
REFERENCES:
patent: 4935341 (1990-06-01), Barbmann et al.
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5367060 (1994-11-01), Vandlen et al.
Holmes et al Science vol. 256 p. 1205, May 1992.
Wen et al Cell vol. 69 p. 559, May 1992.
Lupu et al, PNAS, USA vol. 89 p. 2287, Mar. 1992.
Dobashi et al PNSA, USA vol. 88 p. 8582, Oct. 1991.
Benveniste, E.N. et al., P.N.A.S., "Purification and characterization of a human T-lymphocyte-derived glial growth promoting factor", 82: 3930-3934, Jun. 1985.
Kimura, H. et al., "Nature, Structure, expression and function of a Schwannoma derived growth factor", 348: 257-260, Nov. 15, 1990.
Falls et al., Cell, ARIA, a Protein that stimulates acetypoholine receptor synthesis, is a member of the Neu Ligand family, 72: 801-815 (1993).
Plowman et al., Nature, Heregulin induces tyrosine phosphorylation of HER4/p180.sup.erbB4, 366: 473. (1993).
Brockes et al., "Purification and Preliminary Characterization of a Glial Growth Factor from the Bovine Pituitary", J. Biol. Chem. 255: 18, 8374-8377 (Sep. 1980).
Brockes et al., "The neuron as a source of mitogen: its influence on the proliferation of glial and non-neural cells", Garrod and Feldman eds, pp. 309-327 (1980).
Lemke et al. "An Immunochemical Approach to the Purification and Characterization of Glial Growth Factor", Monoclonal Antibodies to Neural Antigens, McKay, Raff and Reichardt, eds. pp. 133-140 (1981).
Lemke et al., "Identification and Purification of Glial Growth Factor.sup.1 ", J. Neuroscience, vol. 4, No. 1, pp. 75-83 (Jan. 1984).
Brockes, "Assay and Isolation of Glial Growth Factor from the Bovine Pituitary", Methods in Enzymology, 147: 217-225 (1987).
Davis et al., "Platelet-derived Growth Factors and Fibroblasts Growth Factors Are Mitogens for Rat Schwann Cells", J. Cell Biology 110: 1353 (Apr. 1990).
Peles et al., "Isolation of the Neu/HER-2 Stimulatory Ligand: A 44 kd Glycoprotein That Induces Differentiation of Mammary Tumor Cells", Cell 69: 205 (Apr. 1992).
Lupu et al., "Direct Intera-tion of a Ligand for the erbB2 Oncogene Product with the EGF Receptor and p185.sup.erbB2 ", Science 249: 1552 (Sep. 1990).
Yarden et al., "Biochemical Analysis of the Ligand for the neu Oncogenic Receptor", Biochemistry 30: 3543 (1991).
Dobashi et al., "Characterization of a neu/c-erbB-2 protein-specific activating factor", P.N.A.S., U.S.A. 88: 8582 (Oct. 1991).
Tarakhovsky et al., "A 25 kDa polypeptide in the ligand for p185neu and is secreted by activated macrophages", Oncogene 6: 2187 (1991).
Davis et al., "Isolation and characterization of a neu protein-specific activating factor from human ATL-2 cell conditioned medium", Biochem. Biophys. Research Communications 179: 1536 (Sep. 1991).
Huang et al. "Purification and Characterization of the neu/erb B2 Ligand-Growth Factor from Bovine Kidney", J. Biol. Chem. 257: 11508 (Jun. 1992).
Lupu et al., "Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses", P.N.A.S., U.S.A. 89: 2287 (Mar. 1992).
Holmes et al., "Identification of Heregulin, a Specific Activator of p185.sup.erbB2 ", Science 256: 1205 (May 1992).
Wen et al., "Neu Differentiation Factor: A Transmembrane Glycoprotein Containing an EGF Domain and an Immunoglobulin Homology Unit", Cell 69: 559 (May 1992).
Yarden, "Growth Factor Receptor Tyrosine Kinases", Ann. Rev. Biochem. 57: 443-478 (1988).
World Patents Index, week 7123, class B04, AN=71-400056S, Derwent Publications, Abstract, Teikoku Hormone Manuf. Ltd. (1996).
Chen Mario Su
Goodearl Andrew
Hiles Ian
Marchioni Mark
Minghetti Luisa
Cambridge NeuroScience, Inc.
Huff Sheela
Ludwig Institute for Cancer Research
LandOfFree
Glial mitogenic factors, their preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glial mitogenic factors, their preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glial mitogenic factors, their preparation and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1424915